APLMWNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$33.594 K
$0.01 +0.00%
Close of 23 Sept 2026
Revenue
—
Not reported
Earnings
—
Not reported
Shares outstanding
2,196,052
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Apollomics lists more than one class of stock. Company figures above cover all classes combined.
Insiders buying
All insider buying →3 open-market purchases by officers and directors of Apollomics, worth $8.25M. Grants and option exercises are excluded.
536,667 shares at $14.07 on 14 Aug 2026 · filed 17 Aug 2026
26,667 shares at $15.00 on 14 Aug 2026 · filed 17 Aug 2026
20,000 shares at $15.00 on 14 Aug 2026 · filed 17 Aug 2026
Where these numbers come from
Share counts and financials for Apollomics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.